Fasiglifam (TAK-875) has dual potentiating mechanisms via Gαq-GPR40/FFAR1 signaling branches on glucose-dependent insulin secretion.
Pharmacol Res Perspect
; 4(3): e00237, 2016 Jun.
Article
in En
| MEDLINE
| ID: mdl-27433346
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Pharmacol Res Perspect
Year:
2016
Document type:
Article
Country of publication: